Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) were up 4.5% during mid-day trading on Friday . The stock traded as high as $18.55 and last traded at $18.4650. Approximately 2,678,073 shares changed hands during trading, an increase of 6% from the average daily volume of 2,538,315 shares. The stock had previously closed at $17.67.
Analyst Upgrades and Downgrades
SBRA has been the subject of a number of recent analyst reports. Cantor Fitzgerald raised their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. UBS Group increased their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Wells Fargo & Company raised their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday. Truist Financial boosted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, March 13th. Finally, Scotiabank upped their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “sector perform” rating in a research note on Thursday, May 21st. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Sabra Healthcare REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.40.
View Our Latest Stock Report on SBRA
Sabra Healthcare REIT Stock Up 4.5%
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. The firm had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same period last year, the business posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current year.
Sabra Healthcare REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.
Institutional Investors Weigh In On Sabra Healthcare REIT
A number of institutional investors have recently modified their holdings of the business. Focus Partners Wealth grew its holdings in shares of Sabra Healthcare REIT by 11.4% during the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock valued at $404,000 after purchasing an additional 2,375 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 1,536 shares during the last quarter. First Trust Advisors LP lifted its holdings in shares of Sabra Healthcare REIT by 27.2% in the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock worth $6,793,000 after purchasing an additional 78,709 shares during the last quarter. Cerity Partners LLC boosted its position in Sabra Healthcare REIT by 73.0% during the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after purchasing an additional 7,885 shares during the period. Finally, Daiwa Securities Group Inc. grew its stake in Sabra Healthcare REIT by 3.1% during the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock worth $1,547,000 after buying an additional 2,557 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.
About Sabra Healthcare REIT
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
Featured Stories
- Five stocks we like better than Sabra Healthcare REIT
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
